Eye Health News and Research

Latest Eye Health News and Research

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a €3 million grant from the Flemish agency for Innovation by Science and Technology.

10 Mar 2014

Eye health experts across Commonwealth join forces to combat avoidable blindness

A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.

10 Mar 2014

Aetna honored with 2014 Innovation in Reducing Health Care Disparities Award

Aetna was honored today by the National Business Group on Health (NBGH) with the 2014 Innovation in Reducing Health Care Disparities Award. Aetna is a three-time recipient of the award that recognizes organizations for their commitment to equality in health care and exceptional support for cultural diversity.

8 Mar 2014

Research paper takes broader snapshot of returning soldiers' mental state

Much of the research on post-combat mental health of veterans focuses on problems like post-traumatic stress disorder (PTSD) and major depression. A paper co-authored by R. Tyson Smith, visiting assistant professor of sociology, takes an even broader snapshot of returning soldiers' mental state by focusing instead on the identity conflict many face when transitioning from soldier to civilian life and how that conflict manifests as mental distress.

7 Mar 2014

Research explores new diagnostic strategies to detect glaucoma

Research exploring several new diagnostic strategies to find the earliest changes in the eye to detect glaucoma is underway at the University of Alabama at Birmingham School of Optometry. One optometrist says awareness of this eye disorder is just as important as continuing to study it.

7 Mar 2014

Medicaid expansion: With Arkansas 'private' plan authorized for another year, officials now focus on possible fixes

After surviving an effort earlier this week to defund it, supporters of the state's private option are now working on alterations that will smooth its future. Meanwhile, the back-and-forth over whether to pursue the expansion continues in Virginia and Utah.

7 Mar 2014

Cataract surgery followed by use of contact lenses may be better solution for infants

For adults and children who undergo cataract surgery, implantation of an artificial lens is the standard of care. But a clinical trial suggests that for most infants, surgery followed by the use of contact lenses for several years—and an eventual lens implant—may be the better solution.

7 Mar 2014

Ohr Pharmaceutical partners with CSHL to develop trodusquemine and related analogs

Ohr Pharmaceutical, a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) today announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogs.

6 Mar 2014

First Edition: March 6, 2014

Today's headlines include reports about health law rule changes announced yesterday by the Obama administration.

6 Mar 2014

Tips to ease daylight saving time transition

Daylight saving time begins at 2 a.m. on Sunday, March 9, bringing more sunshine in the evenings at the price of an hour of sleep. Vanderbilt Sleep Disorders Center specialist Kelly Brown, M.D., says a little extra planning can alleviate that groggy feeling that often accompanies the time change.

6 Mar 2014

Atypical development can be spotted at 12 months of age among siblings of children with autism

Atypical development can be detected as early as 12 months of age among the siblings of children with autism spectrum disorder, a study published by researchers with the UC Davis MIND Institute and UCLA has found.

6 Mar 2014

Kamada initiates Phase 2/3 clinical trial of Glassia to treat pediatric patients with T1D

Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces the initiation of a Phase 2/3 clinical trial of Glassia®, the Company's proprietary human Alpha-1 Antitrypsin (AAT), to treat newly diagnosed pediatric patients with type 1 diabetes (T1D).

5 Mar 2014

Tel Aviv University researchers discover link between sharp vision and the brain's processing speed

Middle-aged adults who suddenly need reading glasses, patients with traumatic brain injuries, and people with visual disorders such as "lazy eye" may have one thing in common --"visual crowding," an inability to recognize individual items surrounded by multiple objects. Visual crowding makes it impossible to read, as single letters within words are rendered illegible. And basic cognitive functions such as facial recognition can also be significantly hampered. Scientists and clinicians currently attribute crowding to a disorder in peripheral vision.

5 Mar 2014

Rigel Pharmaceuticals reports net loss of $16.9 million for fourth quarter 2013

Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.

4 Mar 2014

Neuropsychologists develop new technique to restore patients' perception of sounds and images

Stroke is one of the most common neurological disorders worldwide. Many stroke survivors are left with serious health problems. Some patients, for example, find themselves unable to perceive one side of their body and can have problems seeing, hearing and feeling on that side.

4 Mar 2014

Nanomedicine – Past, Present and Future

News-Medical speaks to Frank Boehm about the fundamentals of nanomedicine and the nanotechnologies of the future.

4 Mar 2014

Loyola physician sheds light on common and painful viral infection, shingles

Shingles is a painful viral infection that affects almost one million people worldwide and 30 percent of Americans every year.

4 Mar 2014

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering.

4 Mar 2014

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).

4 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

Eye Health News and Research

Latest Eye Health News and Research

ThromboGenics receives IWT grant to study potential new biotherapeutics for DME

Eye health experts across Commonwealth join forces to combat avoidable blindness

Aetna honored with 2014 Innovation in Reducing Health Care Disparities Award

Research paper takes broader snapshot of returning soldiers' mental state

Research explores new diagnostic strategies to detect glaucoma

Medicaid expansion: With Arkansas 'private' plan authorized for another year, officials now focus on possible fixes

Cataract surgery followed by use of contact lenses may be better solution for infants

Ohr Pharmaceutical partners with CSHL to develop trodusquemine and related analogs

First Edition: March 6, 2014

Tips to ease daylight saving time transition

Atypical development can be spotted at 12 months of age among siblings of children with autism

Kamada initiates Phase 2/3 clinical trial of Glassia to treat pediatric patients with T1D

Tel Aviv University researchers discover link between sharp vision and the brain's processing speed

Rigel Pharmaceuticals reports net loss of $16.9 million for fourth quarter 2013

Neuropsychologists develop new technique to restore patients' perception of sounds and images

Nanomedicine – Past, Present and Future

Loyola physician sheds light on common and painful viral infection, shingles

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Genetics & Genomics - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in